Project Details
Description
DEFEND 2: Durable-Response Therapy Evaluation for Early- or New-Onset Type 1 Diabetes
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/10 → 7/31/13 |
Funding
- Tolerx, Inc.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.